Lactylation in health and disease: physiological or pathological?
Theranostics · 02.01.2025 · 15 (5) · 1787-1821
DOI: 10.7150/thno.105353 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, erschienen am 02.01.2025. Verfasst von Lijun Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and Department of Immunology, Fourth Military Medical University, Xi'an…. Hauptthemen laut MEDLINE: Protein Processing, Post-Translational, Lactic Acid. Die Arbeit wurde bisher 77-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Lactate is an indispensable substance in various cellular physiological functions and plays regulatory roles in different aspects of energy metabolism and signal transduction. Lactylation (Kla), a key pathway through which lactate exerts its functions, has been identified as a novel posttranslational modification (PTM). Research indicates that Kla is an essential balancing mechanism in a variety of organisms and is involved in many key cellular biological processes through different pathways. Kla is closely related to disease development and represents a potential and important new drug target. In line with existing reports, we searched for newly discovered Kla sites on histone and nonhistone proteins; reviewed the regulatory mechanisms of Kla (particularly focusing on the enzymes directly involved in the reversible regulation of Kla, including "writers" (modifying enzymes), "readers" (modification-binding enzymes), and "erasers" (demodifying enzymes); and summarized the crosstalk between different PTMs to help researchers better understand the widespread distribution of Kla and its diverse functions. Furthermore, considering the "double-edged sword" role of Kla in both physiological and pathological contexts, this review highlights the "beneficial" biological functions of Kla in physiological states (energy metabolism, inflammatory responses, cell fate determination, development, etc.) and its "detrimental" pathogenic or inducive effects on pathological processes, particularly malignant tumors and complex nontumor diseases. We also clarify the molecular mechanisms of Kla in health and disease, and discuss its feasibility as a therapeutic target. Finally, we describe the detection technologies for Kla and their potential applications in diagnosis and clinical settings, aiming to provide new insights for the treatment of various diseases and to accelerate translation from laboratory research to clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and Department of Immunology, Fourth Military Medical University, Xi'an, Shanxi 710032, China.
- Henan Key Laboratory of Immunology and Targeted Drugs, Xinxiang Key Laboratory of Tumor Microenvironment and Immunotherapy, School of Medical Technology, Xinxiang Medical University, Xinxiang, Henan, China.
Zitieren
APA
Zhao, L., Qi, H., Lv, H., Liu, W., Zhang, R., & Yang, A. (2025). Lactylation in health and disease: physiological or pathological?. Theranostics, 15(5), 1787-1821. https://doi.org/10.7150/thno.105353
Vancouver
Zhao L, Qi H, Lv H, Liu W, Zhang R, Yang A. Lactylation in health and disease: physiological or pathological?. Theranostics. 2025;15(5):1787-1821. doi:10.7150/thno.105353
BibTeX
@article{Zhao2025,
author = {Zhao, Lijun and Qi, Haonan and Lv, Huiying and Liu, Wenyue and Zhang, Rui and Yang, Angang},
title = {Lactylation in health and disease: physiological or pathological?},
journal = {Theranostics},
year = {2025},
volume = {15},
number = {5},
pages = {1787--1821},
doi = {10.7150/thno.105353}
}
EUVIMED